Search

everythinglearnresearchcommunity

for

Search:↓

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Increasing SSAT makes skin more prone to cancer.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Reporter characteristics affect detection of hair loss from cancer therapy.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The Foxn1(-/-) phenotype disrupts hair growth and affects skin stem cells.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Macrophages help maintain mammary stem cells and balance through specific signaling.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.